Iannazzo, S., Mannucci, E., & Mantovani, L. (2016). [Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways, 17(1), 19–27. https://doi.org/10.7175/fe.v17i1.1238